Disruption of blood flow in the outflow graft is a valuable marker for detecting suction events in patients with continuous-flow left ventricular assist devices
- 8 Downloads
Compliance with ethical standards
Conflict of interest
Hiroyuki Tsutsui received honoraria from Otsuka, Takeda Pharmaceutical, Mitsubishi-Tanabe Pharma, Daiichi Sankyo, Nippon Boehringer, Bayer Yakuhin, and Pfizer. Hiroyuki Tsutsui received manuscript fees from Igaku-shoin and Medical View. Hiroyuki Tsutsui received research funding from Nippon Boehringer and Mitsubishi-Tanabe Pharma. Tasuku Sato, Takeo Fujino, Taiki Higo, Kisho Ohtani, Ken-ichi Hiasa, and Akira Shiose declare that they have no conflict of interest.
Human rights statements
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions.
Informed consent was obtained from all patients for being included in the study.